Literature DB >> 34604417

Whole-Exome Sequencing Identified a Novel Variant (C.405_422+39del) in DSP Gene in an Iranian Pedigree with Familial Dilated Cardiomyopathy.

Yeganeh Eshaghkhani1, Arezoo Mohamadifar2, Mostafa Asadollahi1, Mahdieh Taghizadeh3, Arezou Karamzade1, Mohammad Saberi1, Parisa Nourmohammadi3, Zahra Golchehre1, Ahmad Amin2, Mohammad Keramatipour1,3.   

Abstract

BACKGROUND: Dilated cardiomyopathy (DCM) is a progressive heart condition characterized by left ventricular chamber enlargement associated with systolic heart failure and prolonged action potential duration. Genetic variations in genes that encode cytoskeleton, sarcomere, and nuclear envelope proteins are responsible for 45% of cases. In our study, we focused on a pedigree with familial DCM to decipher the potential genetic cause(s) in affected members developing arrhythmia, end-stage heart failure, and sudden death.
METHODS: Whole-exome sequencing (WES) was exploited for a 27-year-old heart-transplanted female as the proband, and the derived data were filtered using the standard pipelines.
RESULTS: A 57-nucleotide deletion (c.405_422+39del) in the desmoplakin gene (DSP) (NM_004415.4) was identified as a novel pathogenic variant. Familial segregation analysis indicated that this variant is present in clinically affected members and absent in unaffected members.
CONCLUSION: It seems that the detected variant induces intron retention, resulting in a premature stop codon in intron 3 of DSP leading to production of a truncated, nonfunctional protein. Additionally, it can trigger a nonsense-mediated mRNA decay pathway associated with inhibition of protein production. The present study results illustrated that a novel deletion in DSP can cause DCM in an Iranian family.

Entities:  

Keywords:  Desmoplakin; Dilated cardiomyopathy; Pathogenic variant; Whole exome sequencing

Year:  2021        PMID: 34604417      PMCID: PMC8480302          DOI: 10.52547/rbmb.10.2.280

Source DB:  PubMed          Journal:  Rep Biochem Mol Biol        ISSN: 2322-3480


  23 in total

Review 1.  Cardiomyopathy. Diagnosis and management of dilated cardiomyopathy.

Authors:  P Elliott
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

Review 2.  Dilated cardiomyopathy.

Authors:  Robert G Weintraub; Christopher Semsarian; Peter Macdonald
Journal:  Lancet       Date:  2017-02-10       Impact factor: 79.321

Review 3.  Next-generation sequencing to identify genetic causes of cardiomyopathies.

Authors:  Nadine Norton; Duanxiang Li; Ray E Hershberger
Journal:  Curr Opin Cardiol       Date:  2012-05       Impact factor: 2.161

4.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

5.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Alessandra Rampazzo; Andrea Nava; Sandro Malacrida; Giorgia Beffagna; Barbara Bauce; Valeria Rossi; Rosanna Zimbello; Barbara Simionati; Cristina Basso; Gaetano Thiene; Jeffrey A Towbin; Gian A Danieli
Journal:  Am J Hum Genet       Date:  2002-10-08       Impact factor: 11.025

Review 6.  Genetics and genetic testing of dilated cardiomyopathy: a new perspective.

Authors:  Luisa Mestroni; Matthew R G Taylor
Journal:  Discov Med       Date:  2013-01       Impact factor: 2.970

7.  Atlas of the clinical genetics of human dilated cardiomyopathy.

Authors:  Jan Haas; Karen S Frese; Barbara Peil; Wanda Kloos; Andreas Keller; Rouven Nietsch; Zhu Feng; Sabine Müller; Elham Kayvanpour; Britta Vogel; Farbod Sedaghat-Hamedani; Wei-Keat Lim; Xiaohong Zhao; Dmitriy Fradkin; Doreen Köhler; Simon Fischer; Jennifer Franke; Sabine Marquart; Ioana Barb; Daniel Tian Li; Ali Amr; Philipp Ehlermann; Derliz Mereles; Tanja Weis; Sarah Hassel; Andreas Kremer; Vanessa King; Emil Wirsz; Richard Isnard; Michel Komajda; Alessandra Serio; Maurizia Grasso; Petros Syrris; Eleanor Wicks; Vincent Plagnol; Luis Lopes; Tenna Gadgaard; Hans Eiskjær; Mads Jørgensen; Diego Garcia-Giustiniani; Martin Ortiz-Genga; Maria G Crespo-Leiro; Rondal H Lekanne Dit Deprez; Imke Christiaans; Ingrid A van Rijsingen; Arthur A Wilde; Anders Waldenstrom; Martino Bolognesi; Riccardo Bellazzi; Stellan Mörner; Justo Lorenzo Bermejo; Lorenzo Monserrat; Eric Villard; Jens Mogensen; Yigal M Pinto; Philippe Charron; Perry Elliott; Eloisa Arbustini; Hugo A Katus; Benjamin Meder
Journal:  Eur Heart J       Date:  2014-08-27       Impact factor: 29.983

Review 8.  The Diagnosis and Evaluation of Dilated Cardiomyopathy.

Authors:  Alan G Japp; Ankur Gulati; Stuart A Cook; Martin R Cowie; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2016-06-28       Impact factor: 24.094

9.  Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms.

Authors:  T B Rasmussen; J Hansen; P H Nissen; J Palmfeldt; S Dalager; U B Jensen; W Y Kim; L Heickendorff; H Mølgaard; H K Jensen; K E Sørensen; U T Baandrup; P Bross; J Mogensen
Journal:  Clin Genet       Date:  2012-12-03       Impact factor: 4.438

10.  Defining the interactions between intermediate filaments and desmosomes.

Authors:  E A Smith; E Fuchs
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

View more
  2 in total

1.  Dilated cardiomyopathy caused by a pathogenic nucleotide variant in RBM20 in an Iranian family.

Authors:  Mahshid Malakootian; Mahrokh Bagheri Moghaddam; Samira Kalayinia; Melody Farrashi; Majid Maleki; Parham Sadeghipour; Ahmad Amin
Journal:  BMC Med Genomics       Date:  2022-05-08       Impact factor: 3.622

2.  Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis.

Authors:  Jinjin Zhang; Lei Wang; Zhikun Zhao; Liang Li; Yunfeng Xia
Journal:  J Healthc Eng       Date:  2021-12-16       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.